Bikash Medhi

InstitutionDepartment of Pharmacology
AddressChandigarh
India
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 40 Covid-19 publications, with a maximum of 5 publications in Spetember 2020 and January 2021
    All Publications
    Bar chart showing 116 publications over 17 distinct years, with a maximum of 18 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prajapat M, Handa V, Sarma P, Prakash A, Kaur H, Sharma S, Bhattacharyya A, Kumar S, Sharma AR, Avti P, Medhi B. Update on geographical variation and distribution of SARS-nCoV-2: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):310-316. PMID: 34414910.
      Citations:    Fields:    Translation:Humans
    2. Bhattacharyya A, Sarma P, Sharma DJ, Das KK, Kaur H, Prajapat M, Kumar S, Bansal S, Prakash A, Avti P, Thota P, Reddy DH, Gautam BS, Medhi B. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jul-Aug; 53(4):317-327. PMID: 34414911.
      Citations: 3     Fields:    Translation:Humans
    3. Prakash A, Singh H, Sarma P, Bhattacharyya A, Dhibar DP, Balaini N, Shree R, Goyal M, Modi M, Medhi B. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis. Sci Rep. 2021 06 18; 11(1):12888. PMID: 34145351.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Singh RS, Singh A, Kaur H, Batra G, Sarma P, Kaur H, Bhattacharyya A, Sharma AR, Kumar S, Upadhyay S, Tiwari V, Avti P, Prakash A, Medhi B. Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review. Phytother Res. 2021 Aug; 35(8):4456-4484. PMID: 34132429.
      Citations: 1     Fields:    Translation:HumansAnimals
    5. Kaur H, Sarma P, Bhattacharyya A, Sharma S, Chhimpa N, Prajapat M, Prakash A, Kumar S, Singh A, Singh R, Avti P, Thota P, Medhi B. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors "leflunomide" and "teriflunomide" in Covid-19: A narrative review. Eur J Pharmacol. 2021 Sep 05; 906:174233. PMID: 34111397.
      Citations:    Fields:    Translation:HumansAnimals
    6. Chauhan A, Avti P, Shekhar N, Prajapat M, Sarma P, Bhattacharyya A, Kumar S, Kaur H, Prakash A, Medhi B. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD. Comput Biol Med. 2021 07; 134:104495. PMID: 34022485.
      Citations: 1     Fields:    Translation:HumansCells
    7. Avti P, Chauhan A, Shekhar N, Prajapat M, Sarma P, Kaur H, Bhattacharyya A, Kumar S, Prakash A, Sharma S, Medhi B. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings. J Biomol Struct Dyn. 2021 May 13; 1-11. PMID: 33998950.
      Citations: 2     Fields:    
    8. Mahalmani V, Kumaravel J, Jain M, Prakash A, Medhi B. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian J Pharmacol. 2021 May-Jun; 53(3):187-191. PMID: 34169902.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Prakash A, Kaur S, Kaur C, Prabha PK, Bhatacharya A, Sarma P, Medhi B. Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review. Indian J Pharmacol. 2021 May-Jun; 53(3):236-243. PMID: 34169911.
      Citations:    Fields:    Translation:Humans
    10. Bhattacharyya A, Sarma P, Kaur H, Medhi B. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med. 2021 03; 174(3):434. PMID: 33721533.
      Citations: 3     Fields:    Translation:Humans
    11. Kaur H, Sarma P, Bhattacharyya A, Prajapat M, Kumar S, Prakash A, Medhi B. Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539. PMID: 33662863.
      Citations: 4     Fields:    Translation:HumansCells
    12. Mahendiratta S, Bansal S, Sarma P, Kumar H, Choudhary G, Kumar S, Prakash A, Sehgal R, Medhi B. Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021 May; 137:111300. PMID: 33529945.
      Citations: 9     Fields:    Translation:Humans
    13. Kumar S, Sarma P, Kaur H, Prajapat M, Bhattacharyya A, Avti P, Sehkhar N, Kaur H, Bansal S, Mahendiratta S, Mahalmani VM, Singh H, Prakash A, Kuhad A, Medhi B. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review. Tissue Cell. 2021 Jun; 70:101497. PMID: 33550034.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    14. Kaur H, Shekhar N, Sharma S, Sarma P, Prakash A, Medhi B. Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacol Rep. 2021 Jun; 73(3):736-749. PMID: 33389725.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    15. Faruqui AR, Xavier D, Kamat SK, Chandy SJ, Medhi B, Tripathi RK, Shetty YC, Raj JM, Kaushal S, Balakrishnan S, Atal S, Tripathi SK, Badyal DK, Dikshit H, Roy SS, Trivedi N, Chatterjee S, Desai C, Tripathi CD, Rege NN, Gupta P, Raveendran R, Kaul R, Kshirsagar NA. Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):219-226. PMID: 33818480.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    16. Kaur H, Kaur M, Bhattacharyya A, Prajapat M, Thota P, Sarma P, Kumar S, Kaur G, Sharma S, Prakash A, Saifuddin PK, Medhi B. Indian contribution toward biomedical research and development in COVID-19: A systematic review. Indian J Pharmacol. 2021 Jan-Feb; 53(1):63-72. PMID: 33976001.
      Citations: 2     Fields:    Translation:HumansAnimals
    17. Kaushal K, Sarma P, Rana SV, Medhi B, Naithani M. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review. J Biomol Struct Dyn. 2020 Dec 10; 1-16. PMID: 33300456.
      Citations: 7     Fields:    
    18. Dhibar DP, Arora N, Kakkar A, Singla N, Mohindra R, Suri V, Bhalla A, Sharma N, Singh MP, Prakash A, Pvm L, Medhi B. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study. Int J Antimicrob Agents. 2020 Dec; 56(6):106224. PMID: 33166694.
      Citations: 1     Fields:    Translation:Humans
    19. Mahalmani V, Pugazhenthan T, Mittal N, Varthya SB, Medhi B. Regulatory approval for COVID-19 across the globe. Indian J Pharmacol. 2020 Nov-Dec; 52(6):457-466. PMID: 33666185.
      Citations:    Fields:    Translation:PHPublic Health
    20. Sarma P, Bhattacharyya A, Kaur H, Prajapat M, Prakash A, Kumar S, Bansal S, Kirubakaran R, Reddy DH, Muktesh G, Kaushal K, Sharma S, Shekhar N, Avti P, Thota P, Medhi B. Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis. Indian J Pharmacol. 2020 Nov-Dec; 52(6):535-550. PMID: 33666200.
      Citations: 7     Fields:    Translation:Humans
    21. Shekhar N, Sarma P, Prajapat M, Avti P, Kaur H, Raja A, Singh H, Bhattacharya A, Sharma S, Kumar S, Prakash A, Medhi B. In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations. mSystems. 2020 Sep 22; 5(5). PMID: 32963099.
      Citations: 6     
    22. Choubey A, Dehury B, Kumar S, Medhi B, Mondal P. Naltrexone a potential therapeutic candidate for COVID-19. J Biomol Struct Dyn. 2022 02; 40(3):963-970. PMID: 32930058.
      Citations: 6     Fields:    
    23. Singla R, Mishra A, Joshi R, Jha S, Sharma AR, Upadhyay S, Sarma P, Prakash A, Medhi B. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Vet Res Commun. 2020 Nov; 44(3-4):119-130. PMID: 32926266.
      Citations: 20     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    24. Singh H, Kaur H, Medhi B. Novel therapeutic approaches toward Hantaan virus and its clinical features' similarity with COVID-19. Indian J Pharmacol. 2020 Sep-Oct; 52(5):347-355. PMID: 33283765.
      Citations:    Fields:    Translation:HumansAnimalsCellsPHPublic Health
    25. Prakash A, Singh H, Kaur H, Semwal A, Sarma P, Bhattacharyya A, Dhibar DP, Medhi B. Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients. Indian J Pharmacol. 2020 Sep-Oct; 52(5):414-421. PMID: 33283773.
      Citations: 6     Fields:    Translation:Humans
    26. Prajapat M, Shekhar N, Sarma P, Avti P, Singh S, Kaur H, Bhattacharyya A, Kumar S, Sharma S, Prakash A, Medhi B. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model. 2020 12; 101:107716. PMID: 32866780.
      Citations: 18     Fields:    Translation:Cells
    27. Mahendiratta S, Batra G, Sarma P, Kumar H, Bansal S, Kumar S, Prakash A, Sehgal R, Medhi B. Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review. Life Sci. 2020 Oct 01; 258:118207. PMID: 32777301.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    28. Sarma P, Kaur H, Medhi B, Bhattacharyya A. Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2. Graefes Arch Clin Exp Ophthalmol. 2020 11; 258(11):2575-2578. PMID: 32725405.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    29. Sharma AR, Batra G, Kumar M, Mishra A, Singla R, Singh A, Singh RS, Medhi B. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic? Allergol Immunopathol (Madr). 2020 Sep - Oct; 48(5):507-517. PMID: 32653224.
      Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
    30. Mahalmani VM, Semwal A, Kaur H, Kaur S, Prakash A, Medhi B. Pattern of clinical research in the era of COVID-19 pandemic: A new learning experience for the present as well as future. Indian J Pharmacol. 2020 Jul-Aug; 52(4):249-253. PMID: 33078724.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    31. Bhattacharyya A, Kumar S, Sarma P, Kaur H, Prajapat M, Shekhar N, Bansal S, Avti P, Hazarika M, Sharma S, Mahendru D, Prakash A, Medhi B. Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis. Indian J Pharmacol. 2020 Jul-Aug; 52(4):313-323. PMID: 33078733.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    32. Singh A, Singh RS, Sarma P, Batra G, Joshi R, Kaur H, Sharma AR, Prakash A, Medhi B. A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virol Sin. 2020 Jun; 35(3):290-304. PMID: 32607866.
      Citations: 15     Fields:    Translation:AnimalsCellsPHPublic Health
    33. Mahalmani VM, Mahendru D, Sarma P, Prakash A, Medhi B. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. Indian J Pharmacol. 2020 Mar-Apr; 52(2):75-78. PMID: 32565593.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    34. Mahalmani VM, Mahendru D, Semwal A, Kaur S, Kaur H, Sarma P, Prakash A, Medhi B. COVID-19 pandemic: A review based on current evidence. Indian J Pharmacol. 2020 Mar-Apr; 52(2):117-129. PMID: 32565599.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    35. Prajapat M, Sarma P, Shekhar N, Prakash A, Avti P, Bhattacharyya A, Kaur H, Kumar S, Bansal S, Sharma AR, Medhi B. Update on the target structures of SARS-CoV-2: A systematic review. Indian J Pharmacol. 2020 Mar-Apr; 52(2):142-149. PMID: 32565603.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    36. Sarma P, Kaur H, Medhi B, Bhattacharyya A. Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefes Arch Clin Exp Ophthalmol. 2020 11; 258(11):2563-2565. PMID: 32436084.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    37. Sarma P, Shekhar N, Prajapat M, Avti P, Kaur H, Kumar S, Singh S, Kumar H, Prakash A, Dhibar DP, Medhi B. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). J Biomol Struct Dyn. 2021 05; 39(8):2724-2732. PMID: 32266867.
      Citations: 40     Fields:    Translation:HumansCells
    38. Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A, Prajapat M, Shekhar N, Kumar S, Singh R, Singh A, Dhibar DP, Prakash A, Medhi B. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol. 2020 07; 92(7):776-785. PMID: 32297988.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic Health
    39. Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol. 2020 Jan-Feb; 52(1):1-5. PMID: 32201439.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    40. Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B. Drug targets for corona virus: A systematic review. Indian J Pharmacol. 2020 Jan-Feb; 52(1):56-65. PMID: 32201449.
      Citations: 138     Fields:    Translation:HumansCells
    Medhi's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (315)
    Explore
    _
    Co-Authors (144)
    Explore
    _
    Similar People (60)
    Explore
    _